Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
4,031.22
3,477.69
3,154.63
2,860.80
2,470.70
2,132.85
1,905.91
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,031.22
3,477.69
3,154.63
2,860.80
2,470.70
2,132.85
1,905.91
Raw Material Cost
659.75
655.64
680.40
646.46
562.38
534.56
386.80
Purchase of Finished goods
158.44
169.62
125.91
117.01
101.88
69.16
82.44
(Increase) / Decrease In Stocks
60.76
-37.92
-4.12
46.03
-71.31
-126.58
8.87
Employee Cost
950.43
809.91
666.83
561.50
480.26
402.48
356.11
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
1,140.42
918.09
799.57
902.15
674.88
514.08
539.70
Total Expenditure (Excl Depreciation)
2,969.80
2,515.34
2,268.59
2,273.15
1,748.09
1,393.70
1,373.92
Operating Profit (PBDIT) excl Other Income
1,061.42
962.35
886.04
587.65
722.61
739.15
531.99
Other Income
110.64
76.39
56.68
108.04
86.20
23.45
35.50
Operating Profit (PBDIT)
1,172.06
1,038.74
942.72
695.69
808.81
762.60
567.49
Interest
13.75
14.66
5.68
4.71
2.86
5.71
8.29
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
-1.41
Gross Profit (PBDT)
1,158.31
1,024.08
937.04
690.98
805.95
756.89
557.79
Depreciation
127.77
104.33
101.15
97.78
94.14
85.49
69.68
Profit Before Tax
1,030.54
919.75
835.89
593.20
711.81
671.40
488.11
Tax
241.24
224.62
222.44
127.47
150.34
176.79
149.57
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
789.30
695.13
613.45
465.73
561.47
494.61
338.54
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
789.30
695.13
613.45
465.73
561.47
494.61
338.54
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
789.30
695.13
613.45
465.73
561.47
494.61
338.54
Equity Capital
25.07
25.07
25.27
25.71
17.17
17.39
17.54
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
21.91
18.59
16.67
10.5
22.16
20.41
12.32
Operating Profit Margin (Excl OI)
26.33%
27.67%
28.09%
20.54%
29.25%
34.66%
27.91%
Gross Profit Margin
28.73%
29.45%
29.7%
24.15%
32.62%
35.49%
29.27%
PAT Margin
19.58%
19.99%
19.45%
16.28%
22.73%
23.19%
17.76%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 15.92% vs 10.24% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is 13.55% vs 13.31% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 10.29% vs 8.61% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is -6.21% vs 158.10% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024
Compare Nine Monthly Results Of Ajanta Pharma With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
4,031.22
0
4,031.22
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,031.22
0
4,031.22
Raw Material Cost
659.75
0
659.75
Purchase of Finished goods
158.44
0
158.44
(Increase) / Decrease In Stocks
60.76
0
60.76
Employee Cost
950.43
0
950.43
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
1,140.42
0.00
1,140.42
Total Expenditure (Excl Depreciation)
2,969.80
0
2,969.80
Operating Profit (PBDIT) excl Other Income
1,061.42
0.00
1,061.42
Other Income
110.64
0
110.64
Operating Profit (PBDIT)
1,172.06
0
1,172.06
Interest
13.75
0
13.75
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
1,158.31
0
1,158.31
Depreciation
127.77
0
127.77
Profit Before Tax
1,030.54
0
1,030.54
Tax
241.24
0
241.24
Provisions and contingencies
0.00
0
0.00
Profit After Tax
789.30
0
789.30
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
789.30
0
789.30
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
789.30
0
789.30
Equity Capital
25.07
0
25.07
Face Value
2.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
28.73%
0.00%
0.00
28.73%
PAT Margin
19.58%
0.00%
0.00
19.58%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 4,031.22 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 15.92% vs 10.24% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 789.30 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 13.55% vs 13.31% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,061.42 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 10.29% vs 8.61% in Dec 2024
Nine Monthly - Interest
Interest 13.75 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -6.21% vs 158.10% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.33%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024






